Abstract:Background: With the advancement of hepatocellular carcinoma (HCC) treatment technology, the treatment options for HCC patients have increased. However, due to high heterogeneity, among other reasons, the five-year survival rate of patients is still very low. Currently, gene expression prognostic models can suggest more appropriate strategies for the treatment of HCC. This study investigates the role of FAT10 in hepatocarcinogenesis and its underlying mechanism. Methods: The expression of FAT10 was detected by immunohistochemical method using tissue arrays containing 4 specimens of patients with digestive cancer. The expression of FAT10 was determined by a tissue microarray which included 286 pairs of HCC samples and corresponding normal mucosae and was further confirmed by real-time polymerase chain reaction (PCR) and western blot. The Kaplan-Meier survival curve was used to determine the correlation of FAT10 expression with patients' recurrence and overall survival (OS) rate. In vivo, liver fibrosis, cirrhosis, and HCC models were established to assess the FAT10 expression. Moreover, FAT10 over-expressing cell lines were used to determine the molecular mechanism underlying the FAT10-induced cell proliferation and hepatocarcinogenesis by reporter gene measure, real-time PCR, and western blot. Based on TCGA database, signal pathways associated with FAT10 and HCC invasion and metastasis were analyzed by KEGG enrichment analyze. Results: Overexpression of FAT10 in HCC was observed in this study compared with its expression in other digestive tumors. Clinicopathological analysis revealed that FAT10 expression levels were closely associated with tumor diameters and poor prognosis of HCC. This study also confirmed through in vivo experiments that the expression of FAT10 in liver fibrosis, cirrhosis, and HCC gradually increases. Further study revealed that forced FAT10 expression enhanced the growth ability of HCC cells and mediated the degradation of the critical anti-cancer protein p53, which led to carcinogenesis. Finally, 9 signal pathways related to HCC metastasis were obtained through bioinformatics analysis. Conclusions: FAT10 may act as a proto-oncogene that facilitates HCC carcinogenesis by mediating p53 degradation, and the expression of FAT10 is negatively correlated with the prognosis of HCC patients. FAT10 is expected to become a potential combined target and prognostic warning marker for HCC treatment.

As an Independent Prognostic Factor, FAT10 Promotes Hepatitis B Virus-Related Hepatocellular Carcinoma Progression Via Akt/GSK3β Pathway

FAT10 promotes hepatocellular carcinoma (HCC) carcinogenesis by mediating P53 degradation and acts as a prognostic indicator of HCC

FAT10 Level in Human Gastric Cancer and Its Relation with Mutant P53 Level, Lymph Node Metastasis and TNM Staging.

FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma

Expression and biological roles of FAT 10 in gallbladder cancer

The ubiquitin-like protein FAT10 in hepatocellular carcinoma cells limits the efficacy of anti-VEGF therapy

FAT10 overexpression disturbs WISP1 protein and mRNA expression to promote hepatocellular carcinoma progression.

FAT10, an Ubiquitin-Like Protein, Confers Malignant Properties in Non-Tumorigenic and Tumorigenic Cells.

Ubiquitin-like protein FAT10: A potential cardioprotective factor and novel therapeutic target in cancer.

Ubiquitin-related Protein FAT10 and Hepatocellular Carcinoma

Expression and Mutation Analysis of FAT10 Gene in Human Hepatocellular Carcinoma

GRP78 Promotes Hepatocellular Carcinoma proliferation by increasing FAT10 expression through the NF-κB pathway.

Prognostic Significance of FAT10 Expression in Malignant Tumors: a Systematic Review and Meta-Analysis.

Data Supplement from Ubiquitin-like Protein FAT10 Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Modifying β-Catenin Degradation

FAT10: Function and Relationship with Cancer

Relationship between Single Nucleotide Polymorphism of FAT10Gene and Progression of Hepatocellular Carcinoma

Fatty Acid Transport Protein-5 (FATP5) Deficiency Enhances Hepatocellular Carcinoma Progression and Metastasis by Reprogramming Cellular Energy Metabolism and Regulating the AMPK-mTOR Signaling Pathway

High Expression of Gfat1 Predicts Unfavorable Prognosis in Patients with Hepatocellular Carcinoma

Association on the haplotypes of FAT10 gene and hepatocellular carcinoma

BTBD10 is a Prognostic Biomarker Correlated with Immune Infiltration in Hepatocellular Carcinoma.